Clinical Trial

Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)

Study acronym: PASSIFLORE
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
\[68Ga\]Ga-PentixaFor PET-CT will be performed in patients with Small cell lung cancer (SCLC) to confirm the targeting of CXCR4 by \[68Ga\]Ga-PentixaFor
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-28.
Trial Details
NCT Number NCT07007325
Lead Sponsor Institut Cancerologie de l'Ouest
Conditions Small Cell Lung Carcinoma (SCLC)
Enrollment 15 participants
Start Date 2026-09-30
Primary Completion 2028-09-30 (estimated)
Study Completion 2030-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-18